Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Nowadays immunotherapy is a crucial option in the treatment of non-small cell lung cancer. There are a lot of actual options of the first-line therapy for the patients with metastatic lung cancer, including dual immunological blockade of PD-1/PD-L1 and CTLA-4 pathways. This review is an attempt to c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | RU |
| Published: |
IP Habib O.N.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a92e51c914374d90b0dcf921ac158329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|